148 related articles for article (PubMed ID: 33121388)
21. Effect of the presence of remnant thyroid tissue on the serum thyroid hormone balance in thyroidectomized patients.
Ito M; Miyauchi A; Kang S; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nakamura H; Amino N
Eur J Endocrinol; 2015 Sep; 173(3):333-40. PubMed ID: 26077156
[TBL] [Abstract][Full Text] [Related]
22. Pregnancy following operative and complementary treatment of thyroid cancer.
Pomorski L; Bartos M; Narebski J
Zentralbl Gynakol; 2000; 122(7):383-6. PubMed ID: 10951709
[TBL] [Abstract][Full Text] [Related]
23. Hypothyroidism in patients older than 55 years: an analysis of the etiology and assessment of the effectiveness of therapy.
Díez JJ
J Gerontol A Biol Sci Med Sci; 2002 May; 57(5):M315-20. PubMed ID: 11983726
[TBL] [Abstract][Full Text] [Related]
24. Hormone replacement after thyroid and parathyroid surgery.
Schäffler A
Dtsch Arztebl Int; 2010 Nov; 107(47):827-34. PubMed ID: 21173898
[TBL] [Abstract][Full Text] [Related]
25. Clinical Features of Early and Late Postoperative Hypothyroidism After Lobectomy.
Park S; Jeon MJ; Song E; Oh HS; Kim M; Kwon H; Kim TY; Hong SJ; Shong YK; Kim WB; Sung TY; Kim WG
J Clin Endocrinol Metab; 2017 Apr; 102(4):1317-1324. PubMed ID: 28324106
[TBL] [Abstract][Full Text] [Related]
26. Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up.
Kim SY; Kim HJ; Kim SM; Chang H; Lee YS; Chang HS; Park CS
Front Endocrinol (Lausanne); 2020; 11():520. PubMed ID: 32849303
[No Abstract] [Full Text] [Related]
27. Transition from specialist to primary diabetes care: a qualitative study of perspectives of primary care physicians.
Brez S; Rowan M; Malcolm J; Izzi S; Maranger J; Liddy C; Keely E; Ooi TC
BMC Fam Pract; 2009 Jun; 10():39. PubMed ID: 19500397
[TBL] [Abstract][Full Text] [Related]
28. Treatment decisions and adherence to guidelines in the treatment of low risk papillary carcinoma of the thyroid.
Hilly O; Stern-Shavit S; Iran S; Feinmesser R
Isr Med Assoc J; 2014 Sep; 16(9):548-52. PubMed ID: 25351011
[TBL] [Abstract][Full Text] [Related]
29. New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.
Green WL
AAPS J; 2005 Mar; 7(1):E54-8. PubMed ID: 16146330
[TBL] [Abstract][Full Text] [Related]
30. Perspectives on care for young adults with type 1 diabetes transitioning from pediatric to adult health systems: A national survey of pediatric endocrinologists.
Agarwal S; Garvey KC; Raymond JK; Schutta MH
Pediatr Diabetes; 2017 Nov; 18(7):524-531. PubMed ID: 27578432
[TBL] [Abstract][Full Text] [Related]
31. Levothyroxine Supplementation Following Hemithyroidectomy: Incidence, Risk Factors, and Characteristics.
Ahn D; Lee GJ; Sohn JH
Ann Surg Oncol; 2019 Dec; 26(13):4405-4413. PubMed ID: 31489555
[TBL] [Abstract][Full Text] [Related]
32. [Clinical endocrinologists' perception of the deleterious effects of TSH suppressive therapy in patients with differentiated thyroid carcinoma].
Reverter JL; Colomé E; Puig Domingo M; Julián T; Halperin I; Sanmartí A
Endocrinol Nutr; 2010 Oct; 57(8):350-6. PubMed ID: 20494634
[TBL] [Abstract][Full Text] [Related]
33. Body Composition, Resting Energy Expenditure, and Metabolic Changes in Women Diagnosed with Differentiated Thyroid Carcinoma.
Izkhakov E; Vaisman N; Barnes S; Barchana M; Stern N; Keinan-Boker L
Thyroid; 2019 Aug; 29(8):1044-1051. PubMed ID: 31088334
[No Abstract] [Full Text] [Related]
34. Thyroid function after unilateral total lobectomy: risk factors for postoperative hypothyroidism.
De Carlucci D; Tavares MR; Obara MT; Martins LA; Hojaij FC; Cernea CR
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1076-9. PubMed ID: 18936354
[TBL] [Abstract][Full Text] [Related]
35. Thyroid function related symptoms during levothyroxine monotherapy in athyreotic patients.
Ito M; Miyauchi A; Hisakado M; Yoshioka W; Kudo T; Nishihara E; Kihara M; Ito Y; Miya A; Fukata S; Nishikawa M; Nakamura H
Endocr J; 2019 Nov; 66(11):953-960. PubMed ID: 31270299
[TBL] [Abstract][Full Text] [Related]
36. Thyroid cancer survivors' perceptions of survivorship care follow-up options: a cross-sectional, mixed-methods survey.
Bender JL; Wiljer D; Sawka AM; Tsang R; Alkazaz N; Brierley JD
Support Care Cancer; 2016 May; 24(5):2007-2015. PubMed ID: 26530226
[TBL] [Abstract][Full Text] [Related]
37. Association between clinical and tumor features with postoperative thyroglobulin in pediatric papillary thyroid cancer.
Tian T; Jiang L; Zhang X; Huang R; Liu B
Surgery; 2020 Dec; 168(6):1095-1100. PubMed ID: 32948335
[TBL] [Abstract][Full Text] [Related]
38. Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
Dehbi HM; Mallick U; Wadsley J; Newbold K; Harmer C; Hackshaw A
Lancet Diabetes Endocrinol; 2019 Jan; 7(1):44-51. PubMed ID: 30501974
[TBL] [Abstract][Full Text] [Related]
39. Thyrotropin level and thyroid volume for prediction of hypothyroidism following hemithyroidectomy in an Asian patient cohort.
Moon HG; Jung EJ; Park ST; Jung TS; Jeong CY; Ju YT; Lee YJ; Hong SC; Choi SK; Ha WS
World J Surg; 2008 Nov; 32(11):2503-8. PubMed ID: 18758850
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.
Van Tassell B; Wohlford GF; Linderman JD; Smith S; Yavuz S; Pucino F; Celi FS
Thyroid; 2019 Oct; 29(10):1371-1379. PubMed ID: 31364488
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
